Ardelyx, Inc. (ARDX)
5.73
-1.01
(-14.99%)
USD |
NASDAQ |
Feb 20, 16:00
5.76
+0.03
(+0.52%)
After-Hours: 20:00
Ardelyx Shareholders Equity (Quarterly) : 166.95M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 617.97M |
| MannKind Corp. | -44.55M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| PTC Therapeutics, Inc. | -205.31M |
| Fate Therapeutics, Inc. | 234.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 502.81M |
| Total Liabilities (Quarterly) | 335.86M |
| Debt to Equity Ratio | 1.246 |
| Current Ratio | 4.315 |
| Net Debt Paydown Yield | -1.46% |